Publications by authors named "Blanka Vereb"
Introduction: Obesity, type 2 diabetes mellitus and cancers are equally endemic in our country. Their partially common metabolism may constitute the base of their similar epidemiology.
Objective: Proving metabolic relation between glycaemic and nutritional status and progression of cancers, as well as confirming the antitumor effect of non-insulin antidiabetics, primarily metformin.
Article Synopsis
- The rates of cancer and diabetes are rising globally, often occurring together due to shared metabolic processes, prompting the emergence of a new field called oncodiabetology to optimize treatment approaches for these conditions.
- The study focuses on how various cancer treatments impact glucose metabolism and examines the significant diabetogenic side effects of many antineoplastic agents, emphasizing their influence on insulin resistance and production.
- The research also investigates specific types of secondary diabetes, particularly those linked to cancer and its therapies, aiming to clarify the role of oncodiabetology in managing patients with both malignant diseases and diabetes effectively.
Recognition of the commonly encountered colorectal cancer (CRC) generally begins and takes place because of and based on symptoms and signs, due to the unsettled screening of this type of cancer. Sometimes, because of advanced stage cancer urgent surgical intervention could become necessary and, if this is the case, there is no time and possibility for searching for an eventual second tumor and perhaps the patient's status does not permit performing intraoperative investigations either. The incidence of multiple colon cancer is considered to be between 2.
View Article and Find Full Text PDFThe risk of venous thromboembolic events (VTE) in cancer patients is higher than in the general population. Treatment may also increase this risk in these patients. Based on the appropriate criteria (of which the most important are the current ministerial guidelines) thrombosis prophylaxis should be started (given that there is no contraindication) on these patients and be continued while they are at risk.
View Article and Find Full Text PDFThe role of the surgical intervention is decisive in treating colorectal tumors. The neo-adjuvant radio-chemotherapy has improved the efficacy of the treatment of advanced rectum tumors. In order to decrease the size and stage of advanced rectal carcinoma and to increase the rate of resecability, we introduced neoadjuvant radio-chemotherapy.
View Article and Find Full Text PDF